Correlation Between Iteos Therapeutics and BioLineRx
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and BioLineRx, you can compare the effects of market volatilities on Iteos Therapeutics and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and BioLineRx.
Diversification Opportunities for Iteos Therapeutics and BioLineRx
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iteos and BioLineRx is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and BioLineRx go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and BioLineRx
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 0.26 times more return on investment than BioLineRx. However, Iteos Therapeutics is 3.86 times less risky than BioLineRx. It trades about -0.06 of its potential returns per unit of risk. BioLineRx is currently generating about -0.11 per unit of risk. If you would invest 893.00 in Iteos Therapeutics on August 29, 2024 and sell it today you would lose (39.00) from holding Iteos Therapeutics or give up 4.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. BioLineRx
Performance |
| Timeline |
| Iteos Therapeutics |
| BioLineRx |
Iteos Therapeutics and BioLineRx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and BioLineRx
The main advantage of trading using opposite Iteos Therapeutics and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| BioLineRx vs. Ardelyx | BioLineRx vs. Lexicon Pharmaceuticals | BioLineRx vs. Seres Therapeutics | BioLineRx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |